Shared high-risk transcriptional programs across multiple myeloma stages associate with disease progression and poor outcome.
Researchers
Claudio Cerchione, Nour Alassi, Delia Cangini, Sarah Tassinari, Asia Spedaluzzi, Irene Azzali, Sofia Cortesi, Giacomo Feliciani, Alice Rossi, Sonia Ronconi, Michela Ceccolini, Michela Tonelli, Gerardo Musuraca, Nicola Normanno, Emanuela Scarpi, Giorgia Simonetti, Giovanni Martinelli, Paul G Richardson, Matteo Marchesini
Abstract
No abstract available for this article.Source: PubMed (PMID: 43016382)View Original on PubMed